Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enspire DBS Therapy
AddedFeb 15, 2024
UpdatedJun 18, 2026
Enspire DBS Therapy

Enspire DBS Therapy

Enspire DBS Therapy: Enhancing stroke recovery through deep brain stimulation and physical rehabilitation.

HQ
Cleveland, OH, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Enspire DBS Therapy focuses on enhancing stroke recovery through the innovative combination of deep brain stimulation (DBS) and physical rehabilitation. The company aims to restore motor function in stroke patients who continue to experience significant impairment. Enspire DBS offers a comprehensive approach to mediate the effects of stimulation and rehabilitation, providing a promising solution for improving arm function and overall recovery.

The company is currently conducting a clinical trial to evaluate the safety and efficacy of DBS combined with physical therapy. This trial, known as EDEN, is an early feasibility study aimed at understanding the potential benefits of this combined approach. Enspire DBS Therapy's work has the potential to significantly impact stroke recovery treatments, offering new hope for patients with persistent motor impairments.

Enspire DBS Therapy - Quick Facts

When was Enspire DBS Therapy founded?

Enspire DBS Therapy was founded in 2012.

Where is Enspire DBS Therapy's headquarters located?

Enspire DBS Therapy's headquarters is located in Cleveland, OH, US.

When was Enspire DBS Therapy's last funding round?

Enspire DBS Therapy's most recent funding round was for $17.6M (USD) in August 2023.

How much has Enspire DBS Therapy raised to-date?

As of Aug 1, 2023, Enspire DBS Therapy has raised a total of $17.6M (USD).

How many employees does Enspire DBS Therapy have?

Enspire DBS Therapy has 6 employees as of Feb 4, 2024.

Enspire DBS Therapy - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Robotics
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 3 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621340Offices of Physical, Occupational and Speech Therapists, and Audiologists